Skip to main content
. 2020 Nov 5;21(21):8288. doi: 10.3390/ijms21218288
γH2AX Histone H2AX phosphorylated on Ser 139
10H Clone mouse monoclonal anti-PAR antibody (Tulip #1020)
3AB 3-Aminobenzamide (PARP inhibitor)
3i Inhibition of DNA-PK, LigIV, and ATM
4-ANI 4-Amino-1,8-naphthalimide
53BP1 p53 binding protein 1
AG14361 2-[4-[(dimethylamino)methyl]phenyl]-1,3,10-triazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-9-one (PARP-1i)
ATM Ataxia telangiectasia mutated
ATMi ATM inhibitor
ATR Ataxia telangiectasia and Rad3-related protein
ATRi ATR inhibitor
AZ20 4{4-[(3R)3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole
BER Base excision repair
BLEO Bleomycin
BRCA1/2 Breast cancer gene 1 or 2
CDKN2 Cyclin-dependent kinase inhibitor 2
CHK1 Checkpoint kinase 1
CHO9 Chinese hamster ovary 9 cell line
C-NHEJ Canonic-non-homologous End Joining
DAPI 4′,6-diamidino-2-phenylindole (fluorescent DNA marker)
DDI DNA damage index
DDR DNA damage response
DEA 6,9-Diamino-2-ethoxyacridine-DL-lactate monohydrate
DMSO Dimethyl sulfoxide
DNA-PK DNA-dependent protein kinase
DNA-PKi DNA-PK inhibitor
DSBs Double-strand breaks
E-64 trans-Poxysuccinyl-l-leucylamido-(4-guanidino) butane
E7016 10-((4-Hydroxypiperidin-1-yl)methyl)chromeno[4,3,2-de]phthalazin-3(2H)-one (PARPi)
EB 5′-deoxy-5′-[4-[2-[(2,3-dihydro-1oxo-1H-isoindol-4-yl)amino]-2-oxoethyl]-1-piperazinyl]-5′-oxoadenosine dihydrochloride (PARPi)
FBS Fetal bovine serum
HeLa Henrietta Lacks human epithelial carcinoma cell line
HEp-2 Human epithelial type 2 cells
HNSCC Head and neck squamous cell carcinomas
HR Homologous recombination
IC50 The half-maximal inhibitory concentration
ICF Inmunocytofluorescence
INO1001 3-Aminobenzamide (PARP inhibitor)
IR Ionizing radiation
KU-0060648 4-Ethyl-N-[4-[2-(4-morpholinyl)-4-oxo-4H-1-benzopyran-8-yl]-1-dibenzothienyl]-1-piperazineacetamide (DNA-PKi)
KU55933 2-Morpholin-4-yl-6-thianthren-1-yl-pyran-4-one
KU70/80 Ku heterodimer: Ku70 (XRCC6) and Ku80 (XRCC5)
LigIII DNA ligase 3
LigIV DNA ligase 4
LigIVi LigIV inhibitor
MAPK Mitogen-activated protein kinase
MEM Minimum essential medium
MMEJ Microhomology-mediated end joining
MMS Methylmethanosulfonate
MRE11 Complex consisting of meiotic recombination 11
Mst-1 Macrophage-stimulating 1 (mitogen-activated protein kinase)
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
NAD+ Nicotinamide adenine dinucleotide
Nam Nicotinamide
NMuMG Nontransformed mouse mammary gland epithelial cell line
OLA Olaparib (Lynparza, AZD-2281; PARP-1/2 & 3 inhibitor); IUPAC name:4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one
p38 A class of MAPK
PAR Poly(ADP-ribose)
PARG Poly-ADP-glicohidrolase
PARP Poly(ADP-ribosyl) polymerase
PARPis PARP inhibitors
PARylation Poly(ADP-ribosylation)
PBS Phosphate-buffered saline
PFA Paraformaldehyde
Polβ DNA polymerase β
Prexacertib 5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile (CHK1 inhibitor)
PtK2 Male rat kangaroo kidney epithelial cell
RT Room temperature
SSBs Single-strand breaks
TNKS Tankyrase
UV-C Ultraviolet C radiation
VE-821 3-amino-6-(4-methylsulfonylphenyl)-N-phenylpyrazine-2-carboxamide (ATRi)
VE-822 3-[3-[4-(methylaminomethyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine (ATRi)
VERO African green monkey kidney epithelial cell line
VRK1 Vaccinia-related kinase 1
WBWEE1 Western BlotsG2 checkpoint kinase
XRCC1 X-ray repair cross-complementing protein 1